Gelesis Holdings, Inc. Research and Development Expense
Gelesis Holdings, Inc. reported Research and Development Expense of $2.58 million for the 3-month period ending 2023-06-30, per its 10-Q filed 2023-08-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2023-08-14
- Gelesis Holdings, Inc. research and development expense for the quarter ending 2023-06-30 was $2.58M, a 53.25% decline year-over-year.
- Gelesis Holdings, Inc. research and development expense for the quarter ending 2023-03-31 was $3.64M, a 50.92% decline year-over-year.
- Gelesis Holdings, Inc. research and development expense for the quarter ending 2022-12-31 was $2.31M.
- Gelesis Holdings, Inc. research and development expense for the quarter ending 2022-09-30 was $3.37M, a 3.92% increase year-over-year.
- Gelesis Holdings, Inc. research and development expense for fiscal 2022 was $18.61M, a 44.66% increase from fiscal 2021.
- Gelesis Holdings, Inc. research and development expense for fiscal 2021 was $12.87M.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2023-06-30 | $2.58M 10-Q · filed 2023-08-14 | $6.22M 10-Q · filed 2023-08-14 | $8.53M derived: sum of 3 quarters · filed 2023-08-14 | $11.90M derived: sum of 4 quarters · filed 2023-08-14 |
| 2023-03-31 | $3.64M 10-Q · filed 2023-05-15 | $5.95M derived: sum of 2 quarters · filed 2023-05-15 | $9.32M derived: sum of 3 quarters · filed 2023-05-15 | $14.84M derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-12-31 | $2.31M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | $5.68M derived: sum of 2 quarters · filed 2023-03-28 | $11.20M derived: sum of 3 quarters · filed 2023-08-14 | $18.61M 10-K · filed 2023-03-28 |
| 2022-09-30 | $3.37M 10-Q · filed 2022-11-14 | $8.89M derived: sum of 2 quarters · filed 2023-08-14 | $16.30M 10-Q · filed 2022-11-14 | $15.96M derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-06-30 | $5.52M 10-Q · filed 2023-08-14 | $12.93M 10-Q · filed 2023-08-14 | $12.59M derived: sum of 3 quarters · filed 2023-08-14 | $15.83M derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $7.41M 10-Q · filed 2023-05-15 | $7.07M derived: sum of 2 quarters · filed 2023-05-15 | $10.31M derived: sum of 3 quarters · filed 2023-05-15 | $15.90M derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | -$339.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | $2.90M derived: sum of 2 quarters · filed 2023-03-28 | $8.49M derived: sum of 3 quarters · filed 2023-03-28 | $12.87M 10-K · filed 2023-03-28 |
| 2021-09-30 | $3.24M 10-Q · filed 2022-11-14 | $8.83M derived: sum of 2 quarters · filed 2022-11-14 | $13.21M 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $5.59M 10-Q · filed 2022-08-15 | $9.97M 10-Q · filed 2022-08-15 | ||
| 2021-03-31 | $4.38M 10-Q · filed 2022-05-12 |